Cargando…

Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study

Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficul...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakama, Chikako, Tabuchi, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601522/
https://www.ncbi.nlm.nih.gov/pubmed/34793517
http://dx.doi.org/10.1371/journal.pone.0260154
_version_ 1784601369400836096
author Nakama, Chikako
Tabuchi, Takahiro
author_facet Nakama, Chikako
Tabuchi, Takahiro
author_sort Nakama, Chikako
collection PubMed
description Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficulty in quitting smoking, and they may start HTPs use to quit smoking. The purpose of this study is to examine the use of HTPs in people with chronic disease. We used data from an internet study, the Japan Society and New Tobacco Internet Survey (JASTIS). We analyzed 9,008 respondents aged 15–73 years in 2019 using logistic regression. Current use of tobacco products was defined as use within the previous 30 days. Prevalence of current HTP use including dual use and dual use with cigarettes was 9.0% and 6.1% respectively in total. By disease: hypertension 10.2% and 7.4%, diabetes 15.9% and 12.3%, CVD 19.2% and 15.7%, COPD 40.5% and 33.3%, and cancer 17.5% and 11.9%. Diabetes, CVD, COPD, and cancer were positively associated with current use of HTPs (odds ratios (ORs) and 95% confidence intervals (CIs): 1.48 (1.06, 2.07), 2.29 (1.38, 3.80), 3.97(1.73, 9.11), and 3.58(1.99, 6.44), respectively) and dual use of cigarettes and HTPs (ORs and 95% CIs: 2.23 (1.61, 3.09), 3.58 (2.29, 5.60), 7.46 (3.76, 14.80), and 2.57 (1.46, 4.55), respectively) after adjusting for confounders. People with chronic disease were more likely to use HTPs and HTPs together with cigarettes. Further research on the smoking situation of HTPs in patients with chronic diseases is necessary.
format Online
Article
Text
id pubmed-8601522
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86015222021-11-19 Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study Nakama, Chikako Tabuchi, Takahiro PLoS One Research Article Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficulty in quitting smoking, and they may start HTPs use to quit smoking. The purpose of this study is to examine the use of HTPs in people with chronic disease. We used data from an internet study, the Japan Society and New Tobacco Internet Survey (JASTIS). We analyzed 9,008 respondents aged 15–73 years in 2019 using logistic regression. Current use of tobacco products was defined as use within the previous 30 days. Prevalence of current HTP use including dual use and dual use with cigarettes was 9.0% and 6.1% respectively in total. By disease: hypertension 10.2% and 7.4%, diabetes 15.9% and 12.3%, CVD 19.2% and 15.7%, COPD 40.5% and 33.3%, and cancer 17.5% and 11.9%. Diabetes, CVD, COPD, and cancer were positively associated with current use of HTPs (odds ratios (ORs) and 95% confidence intervals (CIs): 1.48 (1.06, 2.07), 2.29 (1.38, 3.80), 3.97(1.73, 9.11), and 3.58(1.99, 6.44), respectively) and dual use of cigarettes and HTPs (ORs and 95% CIs: 2.23 (1.61, 3.09), 3.58 (2.29, 5.60), 7.46 (3.76, 14.80), and 2.57 (1.46, 4.55), respectively) after adjusting for confounders. People with chronic disease were more likely to use HTPs and HTPs together with cigarettes. Further research on the smoking situation of HTPs in patients with chronic diseases is necessary. Public Library of Science 2021-11-18 /pmc/articles/PMC8601522/ /pubmed/34793517 http://dx.doi.org/10.1371/journal.pone.0260154 Text en © 2021 Nakama, Tabuchi https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nakama, Chikako
Tabuchi, Takahiro
Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study
title Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study
title_full Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study
title_fullStr Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study
title_full_unstemmed Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study
title_short Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study
title_sort use of heated tobacco products by people with chronic diseases: the 2019 jastis study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601522/
https://www.ncbi.nlm.nih.gov/pubmed/34793517
http://dx.doi.org/10.1371/journal.pone.0260154
work_keys_str_mv AT nakamachikako useofheatedtobaccoproductsbypeoplewithchronicdiseasesthe2019jastisstudy
AT tabuchitakahiro useofheatedtobaccoproductsbypeoplewithchronicdiseasesthe2019jastisstudy